Cost-Effectiveness of an Antibacterial Envelope for Cardiac Implantable Electronic Device Infection Prevention in the US Healthcare System From the WRAP-IT Trial

In the WRAP-IT trial (Worldwide Randomized Antibiotic Envelope Infection Prevention), adjunctive use of an absorbable antibacterial envelope resulted in a 40% reduction of major cardiac implantable electronic device infection without increased risk of complication in 6983 patients undergoing cardiac...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilkoff, Bruce L., Boriani, Giuseppe, Mittal, Suneet, Poole, Jeanne E., Kennergren, Charles, Corey, G. Ralph, Krahn, Andrew D., Schloss, Edward J., Gallastegui, Jose L., Pickett, Robert A., Evonich, Rudolph F., Roark, Steven F., Sorrentino, Denise M., Sholevar, Darius P., Cronin, Edmond M., Berman, Brett J., Riggio, David W., Khan, Hafiza H., Silver, Marc T., Collier, Jack, Eldadah, Zayd, Holbrook, Reece, Lande, Jeff D., Lexcen, Daniel R., Seshadri, Swathi, Tarakji, Khaldoun G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566304/
https://www.ncbi.nlm.nih.gov/pubmed/32915063
http://dx.doi.org/10.1161/CIRCEP.120.008503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566304/
https://www.ncbi.nlm.nih.gov/pubmed/32915063
http://dx.doi.org/10.1161/CIRCEP.120.008503

Ejemplares similares